Literature DB >> 21800506

Distinct synergistic action of piperacillin and methylglyoxal against Pseudomonas aeruginosa.

Sayanti Mukherjee1, Shaswati Chaki, Sukhen Das, Saswati Sen, Samir Kr Dutta, Sujata G Dastidar.   

Abstract

The dicarbonyl compound methylglyoxal is a natural constituent of Manuka honey produced from Manuka flowers in New Zealand. It is known to possess both anticancer and antibacterial activity. Such observations prompted to investigate the ability of methylglyoxal as a potent drug against multidrug resistant Pseudomonas aeruginosa. A total of 12 test P. aeruginosa strains isolated from various hospitals were tested for their resistances against many antibiotics, most of which are applied in the treatment of P. aeruginosa infections. Results revealed that the strains were resistant to many drugs at high levels, only piperacillin, carbenicillin, amikacin and ciprofloxacin showed resistances at comparatively lower levels. Following multiple experimentations it was observed that methylglyoxal was also antimicrobic against all the strains at comparable levels. Distinct and statistically significant synergism was observed between methylglyoxal and piperacillin by disc diffusion tests when compared with their individual effects. The fractional inhibitory concentration index of this combination evaluated by checkerboard analysis, was 0.5, which confirmed synergism between the pair. Synergism was also noted when methylglyoxal was combined with carbenicillin and amikacin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800506

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  8 in total

1.  Combined antibacterial activity of stingless bee (Apis mellipodae) honey and garlic (Allium sativum) extracts against standard and clinical pathogenic bacteria.

Authors:  Berhanu Andualem
Journal:  Asian Pac J Trop Biomed       Date:  2013-09

2.  Antibacterial effect of Manuka honey on Clostridium difficile.

Authors:  Eric N Hammond; Eric S Donkor
Journal:  BMC Res Notes       Date:  2013-05-07

3.  Biofilm formation of Clostridium difficile and susceptibility to Manuka honey.

Authors:  Eric N Hammond; Eric S Donkor; Charles A Brown
Journal:  BMC Complement Altern Med       Date:  2014-09-03       Impact factor: 3.659

4.  Antibiofilm Activity of Manuka Honey in Combination with Antibiotics.

Authors:  Michelle E M Campeau; Robin Patel
Journal:  Int J Bacteriol       Date:  2014-02-26

5.  Preclinical development of MGO Manuka Honey microemulsion for blepharitis management.

Authors:  Jennifer P Craig; Ilva D Rupenthal; Ali Seyfoddin; Isabella M Y Cheung; Benedict Uy; Michael T M Wang; Grant A Watters; Simon Swift
Journal:  BMJ Open Ophthalmol       Date:  2017-08-07

6.  Correlation of the antibacterial activity of commercial manuka and Leptospermum honeys from Australia and New Zealand with methylglyoxal content and other physicochemical characteristics.

Authors:  Kathryn J Green; Ivan L Lawag; Cornelia Locher; Katherine A Hammer
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

7.  Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Patrick Müller; Dagmar G Alber; Lynne Turnbull; Ralf C Schlothauer; Dee A Carter; Cynthia B Whitchurch; Elizabeth J Harry
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

8.  Improving antibiotic activity against wound pathogens with manuka honey in vitro.

Authors:  Rowena Jenkins; Rose Cooper
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.